Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma

Oral Oncology

Volumn 44, Issue 10, 2008, Pages 915-919

  Chuang, Alice Y ^a   Chuang, Tony C ^a   Chang, Steven ^a   Zhou, Shaoyu ^a   Begum, Shahnaz ^a   Westra, William H ^a   Ha, Patrick K ^a   Koch, Wayne M ^a   Califano, Joseph A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Head and neck squamous cell carcinoma (HNSCC); Human papilloma virus (HPV); Quantitative PCR

Indexed keywords

TUMOR MARKER; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT CANCER; SALIVA ANALYSIS; SAMPLING; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEASIBILITY STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SALIVA; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 51649094603     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.01.001     Document Type: Article

References (24)

1. Ferlay J, Bray F, Pisani P, Parkin D. Globocan 2002: cancer incidence and mortality worldwide., vol. version 2.0. Lyon, France: IARC, 2004.
2. Forastiere A., Koch W., Trotti A., and Sidransky D. Head and neck cancer. N Engl J Med 345 26 (2001) 1890-1900
3. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., and Wu L. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92 9 (2000) 709-720
4. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356 19 (2007) 1944-1956
5. Campisi G., Panzarella V., Giuliani M., Lajolo C., Di Fede O., Falaschini S., et al. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review). Int J Oncol 30 4 (2007) 813-823
6. Ha P.K., Pai S.I., Westra W.H., Gillison M.L., Tong B.C., Sidransky D., et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 8 5 (2002) 1203-1209
7. McKaig R.G., Baric R.S., and Olshan A.F. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 20 3 (1998) 250-265
8. Mork J., Lie A.K., Glattre E., Hallmans G., Jellum E., and Koskela P. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344 15 (2001) 1125-1131
9. Werness B.A., Levine A.J., and Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 4951 (1990) 76-79
10. Kessis T.D., Slebos R.J., Nelson W.G., Kastan M.B., Plunkett B.S., Han S.M., et al. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 90 9 (1993) 3988-3992
11. Genther Williams S.M., Disbrow G.L., Schlegel R., Lee D., Threadgill D.W., and Lambert P.F. Requirement of epidermal growth factor receptor for hyperplasia induced by E5, a high-risk human papillomavirus oncogene. Cancer Res 65 15 (2005) 6534-6542
12. Scheurer M.E., Tortolero-Luna G., and Adler-Storthz K. Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer 15 5 (2005) 727-746
13. Fouret P., Monceaux G., Temam S., Lacourreye L., and St Guily J.L. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 123 5 (1997) 513-516
14. Paz I.B., Cook N., Odom-Maryon T., Xie Y., and Wilczynski S.P. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79 3 (1997) 595-604
15. Sugiyama M., Bhawal U.K., Kawamura M., Ishioka Y., Shigeishi H., Higashikawa K., et al. Human papillomavirus-16 in oral squamous cell carcinoma: clinical correlates and 5-year survival. Br J Oral Maxillofac Surg 45 2 (2007) 116-122
16. Begum S., Gillison M.L., Nicol T.L., and Westra W.H. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 13 4 (2007) 1186-1191
17. Califano J., van der Riet P., Westra W., Nawroz H., Clayman G., Piantadosi S., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56 11 (1996) 2488-2492
18. Hoffmann M., Orlamunder A., Sucher J., Gottschlich S., Gorogh T., Fazel A., et al. HPV16 DNA in histologically confirmed tumour-free neck lymph nodes of head and neck cancers. Anticancer Res 26 1B (2006) 663-670
19. Hoffmann M., Gottschlich S., Gorogh T., Lohrey C., Schwarz E., Ambrosch P., et al. Human papillomaviruses in lymph node neck metastases of head and neck cancers. Acta Otolaryngol 125 4 (2005) 415-421
20. Zhao M., Rosenbaum E., Carvalho A.L., Koch W., Jiang W., Sidransky D., et al. Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer. Int J Cancer 117 4 (2005) 605-610
21. Koskinen W.J., Chen R.W., Leivo I., Makitie A., Back L., Kontio R., et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 107 3 (2003) 401-406
22. Ringstrom E., Peters E., Hasegawa M., Posner M., Liu M., and Kelsey K.T. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8 10 (2002) 3187-3192
23. Dahlgren L., Mellin H., Wangsa D., Heselmeyer-Haddad K., Bjornestal L., Lindholm J., et al. Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Int J Cancer 107 2 (2003) 244-249
24. Smith E.M., Ritchie J.M., Summersgill K.F., Hoffman H.T., Wang D.H., Haugen T.H., et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 96 6 (2004) 449-455